Amdoxovir 145514-04-1
Amdoxovir is an nucleoside reverse transcriptase inhibitor (NRTI) undergoing research for the treatment of HIV. It was discovered by R. F. Schinazi (Emory University) and C. K. Chu (University of Georgia). It is being developed by RFS Pharma. Currently, it is in Phase II clinical studies.
read more [+]| Systematic (IUPAC) name: | [(2R,4R)-4-(2,6-Diaminopurin-9-yl)-1,3-dioxolan-2-yl]methanol |
|---|---|
| Amdoxovir CAS number: | 145514-04-1 |
| ATC code: | 124088 |
| PubChem: | 124088 |
| DrugBank: | |
| Formula: | C9H12N6O3 |
| Molecular mass: | 252.23 g/mol |
| Amdoxovir Assay/Purity: | Typically NLT 98% |
